Exhibiting at K-740
Click Therapeutics, Inc. develops and commercializes software as prescription
medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital TherapeuticsTM enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.